Paysign (NASDAQ:PAYS) Announces Earnings Results, Beats Expectations By $0.02 EPS

Posted by Brenda Bartman on Nov 9th, 2026

Paysign (NASDAQ:PAYS – Get Free Report) released its quarterly earnings results on Monday. The company reported $0.11 EPS for the quarter, beating analysts’ consensus estimates of $0.09 by $0.02, FiscalAI reports. Paysign had a return on equity of 30.13% and a net margin of 15.67%. The business had revenue of $30.80 million during the quarter, compared to analyst estimates of $29.02 million.

Here are the key takeaways from Paysign’s conference call:

Paysign reported record third-quarter revenue of $30.8 million, up 43%, with net income rising more than 200% to $6.7 million. Patient affordability revenue more than doubled, and gross margin expanded 840 basis points to 64.7% as the higher-margin business grew.
The company expects 2026 revenue of $114 million–$117 million and raised its outlook for profitability, forecasting gross margin of 63.5%–64.5%, net income of $23 million–$24 million, and Adjusted EBITDA of $38.5 million–$40 million. It expects to end the year with 190–195 active affordability programs.
A plasma customer is moving 113 centers to another provider by year-end, reducing fourth-quarter revenue by an estimated $1.5 million and gross profit by $700,000. Paysign expects to end 2026 with 445–450 centers, down from 562 at quarter-end, though management expects new centers to offset the loss over the next few quarters.
Apherion’s donor management system remains under regulatory review, with no approval timeline provided. Management said interest is strong in the U.S. and Europe and expects a faster commercial ramp once the product is cleared.

Paysign Stock Performance

NASDAQ:PAYS traded down $2.18 during trading on Monday, reaching $12.51. The company’s stock had a trading volume of 2,641,194 shares, compared to its average volume of 740,079. Paysign has a 12 month low of $3.08 and a 12 month high of $16.15. The firm has a market cap of $706.31 million, a price-to-earnings ratio of 48.12 and a beta of 0.92. The firm has a 50 day moving average of $13.87 and a 200-day moving average of $8.60.

Analysts Set New Price Targets

PAYS has been the topic of a number of recent analyst reports. Lake Street Capital raised their price target on shares of Paysign from $13.00 to $15.00 and gave the company a “buy” rating in a research report on Tuesday, September 15th. Barrington Research set a $15.00 price objective on shares of Paysign in a research report on Tuesday, August 11th. Weiss Ratings raised shares of Paysign from a “buy (b-)” rating to a “buy (b)” rating in a research report on Thursday, October 8th. DA Davidson increased their price objective on shares of Paysign from $12.00 to $15.00 and gave the company a “buy” rating in a research note on Wednesday, September 30th. Finally, Wall Street Zen cut shares of Paysign from a “strong-buy” rating to a “buy” rating in a research report on Sunday, August 16th. Three equities research analysts have rated the stock with a Buy rating. According to data from MarketBeat, the stock presently has an average rating of “Buy” and an average price target of $15.00.

Get Our Latest Stock Report on Paysign

Insiders Place Their Bets

In other news, CEO Mark Newcomer sold 50,000 shares of Paysign stock in a transaction on Friday, October 9th. The stock was sold at an average price of $15.34, for a total transaction of $767,000.00. Following the sale, the chief executive officer directly owned 9,113,002 shares in the company, valued at $139,793,450.68. The trade was a 0.55% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Joan Herman sold 38,900 shares of the business’s stock in a transaction dated Wednesday, September 16th. The stock was sold at an average price of $11.74, for a total transaction of $456,686.00. Following the completion of the transaction, the executive vice president directly owned 609,421 shares in the company, valued at $7,154,602.54. This trade represents a 6.00% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders have sold 294,904 shares of company stock valued at $3,844,124. 24.50% of the stock is currently owned by company insiders.

About Paysign

(Get Free Report)

Paysign, Inc (NASDAQ: PAYS) is a financial technology company that provides payment and prepaid card solutions for businesses and organizations. Its platform supports the issuance, distribution and management of branded prepaid cards and other electronic payment products, helping clients deliver funds to consumers and program participants.

The company serves several specialized markets, including plasma collection centers, pharmaceutical manufacturers and other healthcare-related organizations.